Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Evaluation of Newcastle disease virus mediated dendritic cell activation and cross-priming tumor-specific immune responses ex vivo
Review of the Clinical Evidences of Modulated Electro-Hyperthermia (mEHT) Method: An Update for the Practicing Oncologist
Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN in combination with chemotherapy
Vitamin C protects carboplatin-exposed oocytes from meiotic failure
Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine
Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy
Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies
Immunotherapy Based on Dendritic Cell-Targeted/-Derived Extracellular Vesicles-A Novel Strategy for Enhancement of the Anti-tumor Immune Response
Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment
Dendritic Cell Vaccination in Metastatic Melanoma Turns „Non-T Cell Inflamed“ Into „T-Cell Inflamed“ Tumors
A chirality-dependent action of vitamin C in suppressing Kirsten rat sarcoma mutant tumor growth by the oxidative combination: Rationale for cancer therapeutics
Curcumin and Cancer
Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells
Evaluation of a Recombinant Newcastle Disease Virus Expressing Human IL12 against Human Breast Cancer
2-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3-Phosphate Downregulation
Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer
Blockade of PD-L1 Enhances Cancer Immunotherapy by Regulating Dendritic Cell Maturation and Macrophage Polarization
Past, Current, and Future of Immunotherapies for Prostate Cancer
Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer
The current state of immunotherapy for gliomas: an eye toward the future